Programmed cell death-1 (PD-1) [1,2,3], as an immune checkpoint protein expressing on the surface of activated T cells, plays a fatal role in cancer immunotherapy when interacted with programmed cell death ligand-1 (PD-L1) [4]. Here, CD274 is linked to cancer.